SCHEMBL8770707

SCHEMBL8770707

CCCCCCCCCc1ccc(O)c(C=Cc2ccccc2)c1C=Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.48
MAPT P10636 3/20 0.45
ALOX15 P16050 2/20 0.45
CYP3A4 P08684 2/20 0.45
MEN1 O00255 1/20 0.45
TP53 P04637 1/20 0.45
ALOX5 P09917 1/20 0.45
TSHR P16473 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
BID P55957 3/20 0.43
MCL1 Q07820 3/20 0.43
BCL2L1 Q07817 2/20 0.43
BAK1 Q16611 2/20 0.43
KAT8 Q9H7Z6 2/20 0.43
SAE1 Q9UBE0 2/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
EP300 Q09472 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2356473 0.89 BID (0.54) MAPTALOX15ALOX5BIDMCL1
SCHEMBL11260678 0.84 TYR (0.42) TYRMAPTALOX15CYP3A4MEN1
SCHEMBL8105367 0.83 TYR (0.42) TYRMAPTALOX15CYP3A4MEN1
SCHEMBL7618773 0.82 TYR (0.53) TYRMAPTALOX15CYP3A4MEN1
SCHEMBL29363173 0.82 TYR (0.53) TYRMAPTALOX15CYP3A4MEN1
SCHEMBL18322818 0.82 ALOX5 (0.44) TYRMAPTALOX15CYP3A4MEN1
SCHEMBL17092828 0.78 TRPA1 (0.41) TYRMAPTTP53ALOX5TDP1
SCHEMBL17097101 0.78 TRPA1 (0.41) TYRMAPTTP53ALOX5TDP1
SCHEMBL17092827 0.77 BID (0.52) TYRMAPTALOX15CYP3A4MEN1
Oxirane SCHEMBL5830545 0.76 TYR (0.47) TYRMAPTALOX15CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3119839-B1 TRI-SUBSTITUTED AROMATIC-CONTAINING ADDITIVES AND SURFACTANTS AND METHODS FOR USE RHODIA OPERATIONS (FR) 2019-08-14 EP disclosed
US-9650323-B2 Tri-substituted aromatic-containing additives and surfactants and methods for use RHODIA OPERATIONS (FR) 2017-05-16 US disclosed
EP-3119839-A1 TRI-SUBSTITUTED AROMATIC-CONTAINING ADDITIVES AND SURFACTANTS AND METHODS FOR USE Rhodia Operations (FR) 2017-01-25 EP disclosed
WO-2015143050-A1 TRI-SUBSTITUTED AROMATIC-CONTAINING ADDITIVES AND SURFACTANTS AND METHODS FOR USE RHODIA OPERATIONS (FR) 2015-09-24 WO disclosed
US-20150267035-A1 TRI-SUBSTITUTED AROMATIC-CONTAINING ADDITIVES AND SURFACTANTS AND METHODS FOR USE RHODIA OPERATIONS (FR) 2015-09-24 US disclosed
EP-0796312-A1 SYNERGISTIC ANTIOXIDANT COMBINATIONS FOR LUBRICATING OILS EXXON CHEMICAL PATENTS INC. (US) 1997-09-24 EP disclosed
WO-1996017913-A1 SYNERGISTIC ANTIOXIDANT COMBINATIONS FOR LUBRICATING OILS EXXON CHEMICAL PATENTS INC. (US) 1996-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150267035-A1 TRI-SUBSTITUTED AROMATIC-CONTAINING ADDITIVES AND SURFACTANTS AND METHODS FOR USE TYR, TLR3, TPST2 TYR 1/4885MAPT 114/4885ALOX15 914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.